chrX-136548947-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_016267.4(VGLL1):c.573C>A(p.Asn191Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000165 in 1,210,543 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016267.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VGLL1 | NM_016267.4 | c.573C>A | p.Asn191Lys | missense_variant | 3/5 | ENST00000370634.8 | NP_057351.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VGLL1 | ENST00000370634.8 | c.573C>A | p.Asn191Lys | missense_variant | 3/5 | 1 | NM_016267.4 | ENSP00000359668.3 | ||
VGLL1 | ENST00000440515.5 | c.385+80C>A | intron_variant | 3 | ENSP00000398360.1 | |||||
VGLL1 | ENST00000456412.1 | c.41-1821C>A | intron_variant | 3 | ENSP00000388868.1 |
Frequencies
GnomAD3 genomes AF: 0.00000890 AC: 1AN: 112372Hom.: 0 Cov.: 23 AF XY: 0.0000290 AC XY: 1AN XY: 34514
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1098171Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 1AN XY: 363535
GnomAD4 genome AF: 0.00000890 AC: 1AN: 112372Hom.: 0 Cov.: 23 AF XY: 0.0000290 AC XY: 1AN XY: 34514
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 18, 2024 | The c.573C>A (p.N191K) alteration is located in exon 3 (coding exon 2) of the VGLL1 gene. This alteration results from a C to A substitution at nucleotide position 573, causing the asparagine (N) at amino acid position 191 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at